<code id='CFD8D1CA42'></code><style id='CFD8D1CA42'></style>
    • <acronym id='CFD8D1CA42'></acronym>
      <center id='CFD8D1CA42'><center id='CFD8D1CA42'><tfoot id='CFD8D1CA42'></tfoot></center><abbr id='CFD8D1CA42'><dir id='CFD8D1CA42'><tfoot id='CFD8D1CA42'></tfoot><noframes id='CFD8D1CA42'>

    • <optgroup id='CFD8D1CA42'><strike id='CFD8D1CA42'><sup id='CFD8D1CA42'></sup></strike><code id='CFD8D1CA42'></code></optgroup>
        1. <b id='CFD8D1CA42'><label id='CFD8D1CA42'><select id='CFD8D1CA42'><dt id='CFD8D1CA42'><span id='CFD8D1CA42'></span></dt></select></label></b><u id='CFD8D1CA42'></u>
          <i id='CFD8D1CA42'><strike id='CFD8D1CA42'><tt id='CFD8D1CA42'><pre id='CFD8D1CA42'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:hotspot    - browse:8
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          entertainment